Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.

Okebe J, Bousema T, Affara M, Di Tanna GL, Dabira E, Gaye A, Sanya-Isijola F, Badji H, Correa S, Nwakanma D, Van Geertruyden JP, Drakeley C, D'Alessandro U.

EBioMedicine. 2016 Nov;13:348-355. doi: 10.1016/j.ebiom.2016.10.032. Epub 2016 Oct 23.

2.

Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.

Atroosh WM, Al-Mekhlafi HM, Snounou G, Al-Jasari A, Sady H, Nasr NA, Lau YL, Surin J.

Malar J. 2016 May 27;15(1):295. doi: 10.1186/s12936-016-1344-0.

3.
4.

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.

Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, Drakeley C, Bousema T.

BMC Med. 2016 Mar 8;14:40. doi: 10.1186/s12916-016-0581-y.

5.
6.

Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.

Poirot E, Vittinghoff E, Ishengoma D, Alifrangis M, Carneiro I, Hashim R, Baraka V, Mosha J, Gesase S, Chandramohan D, Gosling R.

PLoS One. 2015 Nov 23;10(11):e0142414. doi: 10.1371/journal.pone.0142414. eCollection 2015.

7.

Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.

Thanh PV, Hong NV, Van NV, Louisa M, Baird K, Xa NX, Peeters Grietens K, Hung le X, Duong TT, Rosanas-Urgell A, Speybroeck N, D'Alessandro U, Erhart A.

Antimicrob Agents Chemother. 2015 Dec;59(12):7411-9. doi: 10.1128/AAC.00791-15. Epub 2015 Sep 21.

8.

Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.

Owusu R, Asante KP, Mahama E, Awini E, Anyorigiya T, Dosoo D, Amu A, Jakpa G, Ofei E, Segbaya S, Oduro AR, Gyapong M, Hodgson A, Bart-Plange C, Owusu-Agyei S.

PLoS One. 2015 Sep 1;10(9):e0136828. doi: 10.1371/journal.pone.0136828. eCollection 2015.

9.

The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial.

Okebe J, Bousema T, Affara M, DiTanna G, Eziefula AC, Jawara M, Nwakanma D, Amambua-Ngwa A, Van Geertruyden JP, Drakeley C, D'Alessandro U.

Trials. 2015 Mar 1;16:70. doi: 10.1186/s13063-015-0597-1.

10.

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. Review.

11.

Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.

Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, Tor P, Chuor CM, Kheng S, Siv S, Kachur PS, Taylor WR, Hwang J, Menard D.

PLoS One. 2014 Dec 26;9(12):e116143. doi: 10.1371/journal.pone.0116143. eCollection 2014.

12.

Primaquine: the risks and the benefits.

Ashley EA, Recht J, White NJ.

Malar J. 2014 Nov 3;13:418. doi: 10.1186/1475-2875-13-418. Review.

13.

Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya.

Shah SS, Macharia A, Makale J, Uyoga S, Kivinen K, Craik R, Hubbart C, Wellems TE, Rockett KA, Kwiatkowski DP, Williams TN.

BMC Med Genet. 2014 Sep 9;15:93. doi: 10.1186/s12881-014-0093-6.

14.

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(2):CD008152.

15.

Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.

Eziefula AC, Pett H, Grignard L, Opus S, Kiggundu M, Kamya MR, Yeung S, Staedke SG, Bousema T, Drakeley C.

Antimicrob Agents Chemother. 2014 Aug;58(8):4971-3. doi: 10.1128/AAC.02889-14. Epub 2014 Jun 9.

16.

The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.

Okebe J, Amambua-Ngwa A, Parr J, Nishimura S, Daswani M, Takem EN, Affara M, Ceesay SJ, Nwakanma D, D'Alessandro U.

Malar J. 2014 Apr 17;13:148. doi: 10.1186/1475-2875-13-148.

17.

Mass drug administration for malaria.

Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J.

Cochrane Database Syst Rev. 2013 Dec 9;(12):CD008846. doi: 10.1002/14651858.CD008846.pub2. Review.

18.

Spatial distribution of G6PD deficiency variants across malaria-endemic regions.

Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI.

Malar J. 2013 Nov 15;12:418. doi: 10.1186/1475-2875-12-418.

19.

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.

Moore BR, Salman S, Benjamin J, Page-Sharp M, Robinson LJ, Waita E, Batty KT, Siba P, Mueller I, Davis TM, Betuela I.

Antimicrob Agents Chemother. 2014;58(1):432-9. doi: 10.1128/AAC.01437-13. Epub 2013 Nov 4.

20.

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.

Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, Fukuda M, Green J, Hwang J, Lacerda M, McGray S, Menard D, Nosten F, Nuchprayoon I, Oo NN, Bualombai P, Pumpradit W, Qian K, Recht J, Roca A, Satimai W, Sovannaroth S, Vestergaard LS, Von Seidlein L.

Malar J. 2013 Nov 4;12:391. doi: 10.1186/1475-2875-12-391.

Supplemental Content

Support Center